New imaging probe tested during bladder tumour removal surgery
Tests a new imaging catheter in adults having bladder tumour removal surgery.
Plain-language title generated from the registry record
Registry title: Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment
Key facts
- Where
- Amsterdam, NetherlandsSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have a suspected bladder tumour and are having it removed through the urethra (TURBT). A new imaging probe is used during the operation.
- Age
- Older than 18 years.
- Sex
- All sexes can join.
- Disease stage
- At least 1 suspected bladder tumour seen at cystoscopy, in a bladder that can be examined with a cystoscope.
Main reasons for not taking part
- Pregnant or breastfeeding women
- The only tumour is at the bladder neck
- Tumour larger than 2 centimetres (0.8 in) in diameter
- More than 5 tumours
- Only a suspected flat lesion
Read by machine on 9 November 2026.
Where in Netherlands
- Amsterdam University Medical CenterAmsterdam, NetherlandsNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Amsterdam UMC
- Trial code
- NCT06679920
- Record updated
- 6 December 2024
- Original description
The goal of this clinical trial is to see if a new designed optical coherence tomography catheter can be used in bladder cancer in patients undergoing a transurethral resection of a bladder tumour. The main question it aims to answer is:Read full original descriptionShow less
IDEAL Phase II Study of a Newly Designed Optical Coherence Tomography Probe During Transurethral Resection for Optimizing Bladder Cancer Diagnosis and Treatment
The goal of this clinical trial is to see if a new designed optical coherence tomography catheter can be used in bladder cancer in patients undergoing a transurethral resection of a bladder tumour. The main question it aims to answer is:
- Is the optical coherence tomography catheter feasible in capturing images of bladder tumours and normal bladder wall during a transurethral resection of a bladder tumour?
Participants will undergo measurements with a new optical coherence tomography device during the transurethral resection of their bladder tumour(s).
Inclusion: Age > 18 years; Have at least 1 suspected bladder tumour seen at cystoscopy; Have a bladder that is accessible for cystoscopy; Be in a physical condition to undergo a TURBT; Eligible patients must be fully informed about the study and written signed informed consent must be obtained prior to any study related investigation/intervention.
Exclusion: Pregnant or lactating women; The only tumour site is at the bladder neck; The tumour(s) is larger than 2 centimetres in diameter; >5 tumours present; Solely a suspected flat lesion present.